Event: 2024 Oligonucleotide Therapeutics Society Meeting (Montreal)
Follow Our Progress
Development and Clinical Progress of RAG-01, a Novel saRNA Targeting p21 for Non-Muscle Invasive Bladder Cancer Treatment. (Abstract)
PUBLICATIONS & PRESENTATIONS